<DOC>
	<DOC>NCT02003534</DOC>
	<brief_summary>This study will evaluate 0.15% brimonidine tartrate in patients with primary open angle glaucoma and ocular hypertension.</brief_summary>
	<brief_title>A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<criteria>Diagnosis of openangle glaucoma or ocular hypertension Used AlphaganÂ® in previous 3 months</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>